PROJECT

Projects

Summary of Investment Information

Project Number

37564

Company Name

MS PHARMA VENTURES HOLDING WLL

Date SPI Disclosed

Apr 10, 2017

Country

Jordan

Region

Middle East

Projected Board Date

Apr 11, 2017

Environmental Category

B - Limited

Status

Active

Last Updated Date

Apr 30, 2017

Department

Regional Industry MAS MCT

Industry

Health, Education and Life Sciences

Previous Events

Approved : Apr 6, 2017
Signed : Apr 12, 2017
Invested : Apr 28, 2017

Sector

Pharmaceuticals and Medicine

Project Description

MS Pharma Ventures Holdings WLL (the “Company”) is a limited liability company incorporated in the Kingdom of Bahrain, active in development, manufacturing and marketing of branded generic pharmaceuticals in Jordan, Algeria, Turkey and other MENA (Middle East and North Africa) countries. Established in 2011 as integrated international pharmaceutical company with three key operating businesses: (i) El Kendi Pharmaceutical Manufacturing Company (Algeria), (ii) United Pharmaceuticals Manufacturing (Jordan), and (iii) MS Pharma Injectibles (Jordan and Turkey). MS Pharma specializes in medication treatment for chronic diseases such as cardiovascular, central nervous system, and respiratory diseases, therapeutic classes which are experiencing high growth rates across MENA region. The Company has invited IFC to support its investment plan of up to US$150 million financing of acquisition opportunities to enter new markets and capacity expansion in its existing facilities (the “Project”).

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation